+ 0.56
+ 0.2%
+ 0.98
+ 0.28%
+ 0.96
+ 0.61%

University Of Pittsburgh Gets $3M Cannabis Research Grant From Parallel

August 7, 2020 12:05 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The University of Pittsburgh School of Medicine and cannabis company Parallel have received approval from the Pennsylvania Department of Health for a clinical research program for the study of medical marijuana.

The 10-year partnership between the medical school and Parallel, and its subsidiary Goodblend, will provide $3 million to study the safety and efficacy of medical cannabis. Their efforts will be focused on sickle cell disease, chronic pain and generalized anxiety disorders.

Fareed Khan, COO and CFO for Parallel, told Benzinga the company is committed to the research of medical cannabis as a treatment for debilitating conditions.

“We are pleased to partner with a global leader in medical research like the University of Pittsburgh to help advance clinical medical cannabis research in the United States,” he said. “This partnership with Pitt, through our GoodBlends brand, will help us continue to develop treatment options for those who may benefit from the therapeutic powers of cannabinoids, empowering more Americans to take control of their personal health and wellness.”

Parallel was formerly known as Surterra Wellness, which launched its global retail brand, GoodBlend, in 2019.

Lead image by Ilona Szentivanyi. Copyright: Benzinga.


Related Articles

Can Legal Cannabis Relieve Fiscal Deficits? These Economists Say 'Not Necessarily'

Legalizing marijuana is often cited as a way to mitigate fiscal deficits for states and countries. But after looking at data from the Canadian market, two bold economists dare to challenge this notion.  read more

Cannabis, Period: Using Marijuana To Relieve Menstrual Symptoms

This article was written by Marian Venini and originally published in El Planteo. read more

Cannabis Movers & Shakers: Avicanna, Halo, Blockers BlockChain, Fyllo, Pet Releaf, Indus

Peruse the latest corporate shake-ups in the cannabis industry: Avicanna, Halo Elect Directors At Annual General Meetings of Shareholders read more

Centri Business Consulting Moderates Panel On Game-Changing Technology For Cannabis Consumers

This special presentation from Centri Business Consulting comes from Benzinga’s Virtual Cannabis Capital Conference that took place on October 15. read more

Verdemed Gives 3 Reasons Why Latin America Is An Interesting Market For Cannabis Companies

This special presentation Verdemed comes from Benzinga’s Virtual Cannabis Capital Conference that took place on October 15. read more